Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Future of cancer nursing

CN12 - Describing self-care behaviours in cancer patients taking oral anticancer agents

Date

22 Sep 2021

Session

Future of cancer nursing

Presenters

Marco Di Nitto

Citation

Annals of Oncology (2021) 32 (suppl_5): S1261-S1265. 10.1016/annonc/annonc692

Authors

M. Di Nitto1, A. Durante1, F. Sollazzo1, V. Biagioli2, L. Rosito1, F. Torino1, R. Alvaro1, E. Vellone1

Author affiliations

  • 1 Biomedicine And Prevention, University of Rome Tor Vergata, 00133 - Rome/IT
  • 2 Dipartimento Biochimica E Prevenzione, Bambino Gesù Children's Hospital IRCSS Rome, Italy - Firenze/IT
More

Resources

Login to access the resources on OncologyPRO.

Abstract CN12

Background

Oral anticancer agents (OAAs) are effective drugs that can be managed autonomously by patients at home with appropriate self-care behaviours. However, OAA-related behaviours have been poorly investigated. The aim of this study was to explore the self-care behaviours adopted by patients treated with OAAs.

Methods

We used a qualitative descriptive design, with semi-structured individual interviews in patients aged ≥70 years and on OAAs for at least 3 months. Interviews were recorded, transcribed verbatim and analysed using content analysis with a deductive and inductive approach. Two investigators independently performed a three-round coding of the text using NVIVO®. We followed the Middle Range Theory of Self-Care of Chronic Illnesses, including the dimensions of self-care maintenance (i.e. behaviours to maintain illness stability), self-care monitoring (i.e. monitoring symptoms and side effects) and self-care management (i.e. actions to respond to symptoms), as an organising framework for extracted codes and categories.

Results

Overall, 22 patients with cancer were interviewed (mean age: 76 [± 5]; male 59.1%; lower secondary school education: 36.36%; tumour site lung: 22.72%). The content analysis yielded 36 codes and 9 categories. Self-care maintenance behaviours included patient strategies for ensuring adherence to OAAs, dietary adaptations and physical activity. Concerning self-care monitoring, patients reported monitoring clinical signs and symptoms related to OAAs intake, monitoring their general health status and attending all follow-up visits as recommended. Self-care management behaviours included both pharmacological and non-pharmacological management of common OAA-related side effects and communicating to the oncology team about any emerging side effects (via phone or during follow-up visits).

Conclusions

This study gives insights into self-care behaviours adopted by patients at home while they are taking OAAs. Evaluating patient self-care behaviours is important for establishing specific interventions aimed at improving patient self-care and patient quality of life by promoting an appropriate and safe use of OAAs.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

M. Di Nitto.

Funding

“Lega Italiana per la Lotta contro i Tumori” (LILT) foundation.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.